A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma: Original article

European Journal of Cancer Care

Volumn 18, Issue 5, 2009, Pages 492-499

  Mabed, M ^a   Esmaeel, M ^a   El Khodary, T ^a   Awad, M ^a   Amer, T ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Chemoembolization; Chemotherapy; Clinical trials; Doxorubicin; Lipidol; Primary hepatocellular carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; IODINATED POPPYSEED OIL;

ADULT; ARTICLE; CHEMOEMBOLIZATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; DOXORUBICIN; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 69149091797     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2008.00984.x     Document Type: Article

References (28)

1. Bronowicki J.P., Boudjema K., Chone L., Nisand G., Bazin C., Pflumio F., Uhl G., Wenger J.J., Jaeck D., Boissel P., Bigard M.A., Gaucher P., Vetter D. Doffoel M. (1996) Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. Journal of Hepatology 24, 293 300.
2. Bruix J. (1997) Treatment of hepatocellular carcinoma. Hepatology 25, 259 262.
3. Bruix J. Llovet J.M. (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35, 519 524.
4. Bruix J., Llovet J.M., Castells A., Montana X., Bru C., Ayuso M.C., Vilana R. Rodes J. (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27, 1578 1583.
5. Bruix J., Sherman M. (2005) Management of hepatocellular carcinoma. Hepatology 42, 1208 1236.
6. Fong Y., Kemeny N. Lawrence T.S. (2001) Cancer of the liver and biliary system. In : Principles and Practice of Oncology, 6th edn (eds DeVita V.T., Hellman S. Rosenberg S.A. pp. 1162 1176. Lippencot-Raven, Philadelphia, PA.
7. Geschwind J.F., Ramsey D.E., Choti M.A., Thuluvath P.J. Huncharek M.S. (2003) Chemoembolization of hepatocellular carcinoma: results of a meta-analysis. American Journal of Clinical Oncology 26, 344 349.
8. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire (1995). A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. The New England Journal of Medicine 332, 1256 1261.
9. Kaplan E.M. Meier P. (1959) Non parametric estimation from incomplete observations. Journal of the American Statistical Association 53, 457 481.
10. Lai C.I., Wu P.C., Chan G.C.B., Lok A.S.F. Lin H.J. (1988) Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. Cancer 62, 479 483.
11. Lai E.C., Choi T.K., Cheng C.H., Mok F.P., Fan S.T., Tan E.S. Wong J. (1990) Doxorubicin for unresectable hepatocellular carcinoma. Cancer 66, 1685 1687.
12. Llovet J.M. Bruix J. (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37, 429 442.
13. Llovet J.M., Real M.I., Montana X., Planas R., Coll S., Aponte J., Ayuso C., Sala M., Muchart J., Sola R., Rodes J., Bruix J. (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable Hepatocellular carcinoma. Lancet 359, 1734 1739.
14. Lo C.M., Ngan H., Tso W.K., Liu C.L., Lam C.M., Poon R.T., Fan S.T. Wong J. (2002) Randomized controlled trial of transarterial ipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35, 1164 1171.
15. Madden M.V., Krige J.E., Bailey S., Beningfield S.J., Geddes C., Werner I.D. Terblanche J. (1993) Randomized trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 34, 1598 1600.
16. Miller A.B., Hoogstraten B. Ataquet M. (1981) Reporting results of cancer treatment. Cancer 47, 207 214.
17. O'Suilleabhain C.B., Poon R.T., Yong J.L., Ooi G.C., Tso W.K. Fan S.T. (2003) Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. The British Journal of Surgery 90, 325 331.
18. Okada S. (1998) Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues (editorial). Hepatology 27, 1743 1744.
19. Okuda K. (1992) Hepatocellular carcinoma: recent progress. Hepatology 15, 948 963.
20. Okuda K., Takayasu K. Okada S. (1998) Treatment selection. In : Liver Cancer (eds Okuda K. Tabor E. pp. 235 236. Churchil Livingtone, Philadelphia, PA.
21. Pelletier G., Roche A., Ink O., Anciaux M.L., Derhy S., Rougier P., Lenoir C., Attali P. Etienne J.P. (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. Journal of Hepatology 11, 181 184.
22. Trevisani F., De Notariis S., Rossi C. Bernardi M. (2001) Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies? Journal of Clinical Gastroenterology 32, 383 389.
23. Whang-Peng J. Chao Y. (1998) Clinical trials of hepatocellular carcinoma in Taiwan. Hepatogastroenterology 45, 1937 1943.
24. Wigmore S.J., Redhead D.N., Thomson B.N., Park R.W. Garden O.J. (2004) Predicting survival in patients with liver cancer considered for transarterial chemoembolization. European Journal of Surgical Oncology 30, 41 45.
25. World Health Organization (WHO) (1979) Handbook for Reporting Results of Cancer Treatment. WHO Offset Publications, Geneva, Switzerland.
26. Yoshimi F., Nagao T., Inoue S., Kawano N., Muto T., Gunji T., Ohnishi S. Imawari M. (1992) Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial. Hepatology 16, 702 706.
27. Yu A.S. Keeffe E.B. (2003) Management of hepatocellular carcinoma. Reviews in Gastroenterological Disorders 3, 8 24.
28. Yuen M.F., Chan A.O., Wong B.C., Hui C.K., Ooi G.C., Tso W.K., Yuan H.J., Wong D.K. Lai C.L. (2003) Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. The American Journal of Gastroenterology 98, 1181 1185.